Brain Sleep Co., Ltd. (Head office: Chiyoda-ku, Tokyo, CEO: Kosuke Michibata, hereinafter referred to as "Brain Sleep") has produced a new sleep treatment program for SAS at the "Sleep/SAS Outpatient Clinic" that "Tsunagu Clinic TOKYO" (Location: Chuo-ku, Tokyo, Supervising Doctor: Masaaki Chiku) will start providing treatment from September 17th. In addition, Seiji Nishino, founder and chief research advisor of Brain Sleep, has been appointed as an outpatient advisor. In our newly established Sleep/SAS Outpatient Clinic, in addition to CPAP treatment, we have developed the optimal treatment program to improve the "sleep" of each patient by introducing oral appliances (mouthpieces) and surgical procedures as a fundamental cure (at our affiliated university hospital), as well as expanding our range of private medical treatments, such as weight loss guidance and sleep counseling. What is SAS (Sleep Apnea Syndrome)? SAS (Sleep Apnea Syndrome) refers to the frequent occurrence of "apnea," where breathing stops for 10 seconds or more, or "hypopnea," the weak breathing just before apnea, during sleep. Specifically, if the number of "apneas and hypopneas" per hour (apnea-hypopnea index = AHI) is 5 or more, SAS (Sleep Apnea Syndrome) is diagnosed. Apnea and hypopnea occur when the tongue falls to the base when sleeping on one's back, blocking the airway, due to an enlarged tongue or a narrow airway to begin with. There are more than 3 million potential patients with sleep apnea syndrome (SAS) Sleep disorders are linked to various diseases, and if you don't get enough sleep due to a sleep disorder, you are at higher risk of developing various diseases such as dementia, stroke, lifestyle-related diseases, and high blood pressure. Among them, sleep apnea syndrome is particularly problematic. The number of potential patients is said to be over 3 million, and is increasing every year. The mainstream treatment for SAS is a treatment method called "CPAP (Continuous Positive Airway Pressure)". However, CPAP is a symptomatic treatment rather than a cure, and once CPAP is used, it is necessary to use it for a long time, which causes a decrease in the patient's quality of life. In addition, it is predicted that the number of people using CPAP therapy will more than double after 2025. This could lead to an increase in national medical expenses as CPAP becomes covered by insurance, making it necessary to establish new treatment methods. A new sleep treatment program for SAS and its future prospects At the newly established Sleep and SAS Outpatient Clinic of Tsunagu Clinic Tokyo, we will prioritize the prompt introduction of CPAP therapy for the treatment of SAS, especially obstructive sleep apnea (OSA). As a next step, we will propose individualized treatment tailored to the severity and cause of each patient. Specifically, we will create a weight loss program (from nutrition counseling to exercise instruction) to address weight gain, which is the most common cause, and depending on the effectiveness of the program, we will aim to take measures and improve the condition using oral appliances (mouthpieces) as an alternative treatment to CPAP. We will also combine this with guidance on sleep positions (adapting your sleeping posture), which are widely used in Europe and the United States, and further expand our sleep counseling focused on improving the quality of sleep. We believe that providing personalized medicine that is optimal for each patient will be a new type of sleep treatment that has never been seen before. In the future, we would like to collect, analyze, and disseminate the effects and knowledge gained from this new treatment program. We also hope to collaborate with various sleep medicine experts, universities, and clinics to establish these treatments as more effective treatments. Details of Medical Corporation Well Aging Tsunagu Clinic TOKYO Tsunagu Clinic Tokyo is a clinic that uses the "Smartphone Consultation" service, which combines online and self-paid medical consultations, to treat lifestyle-related diseases (high blood pressure, dyslipidemia, diabetes, etc.), sleep apnea syndrome (SAS) related to lifestyle-related diseases, smoking cessation, etc. Our clinic aims to reduce medical expenses and mortality rates related to cardiovascular diseases, which have become a social problem. *Treatment for sleep apnea syndrome (SAS) is mainly done through face-to-face consultations. 〒104-0028 Prairie Yaesu Building 6F, 2-5-12 Yaesu, Chuo-ku, Tokyo Clinic website URL: https://www.sumahoshin.or.jp/ Sleep/SAS Clinic Reservation URL: https://www.sleep-clinic.jp/ Consultation hours: 10:00-14:00/15:00-19:00 (Saturdays and holidays - 18:00) *Closed on Sundays and Mondays Tsunagu Clinic Tokyo Sleep and SAS Clinic Advisor: Seiji Nishino Tsunagu Clinic Tokyo Sleep and SAS Outpatient Advisor Seiji Nishino Doctor of Medicine Professor of Psychiatry at the Stanford University School of Medicine and Director of the Stanford University Sleep and Biorhythm Research Center Founder and Chief Research Advisor, Brain Sleep Inc. Certified Qualifications: Mental Health Designated Physician, Japan Society of Sleep Research Specialist Brain Sleep Co., Ltd. Brainsleep was founded in May 2019 with Seiji Nishino, Director of the Stanford University Sleep Biorhythm Laboratory, as its founder and chief research advisor, under the slogan "Live your best life with the best sleep." Brainsleep provides sleep consulting to companies that specialize in sleep, IT-based services, and medically-based sleep information. The company aims to eliminate the sleep debt of Japanese people, who have the shortest sleep time in the world, and lead them to improve their lives. *This is a venture company funded by Anpha Co., Ltd., a preventive medicine company. Established: May 2019 Representative Director: Kosuke Michibata Location: JP Tower 26F, 2-7-2 Marunouchi, Chiyoda-ku, Tokyo Website: https://brain-sleep.com/ Facebook: https://www.facebook.com/brainsleep0508/ [ Click here for the PDF file of the press release ]
Log in
